Navigation Links
Peakdale Molecular Launches AssayReady4U(TM) in Collaboration With ChemPrintCo LLC
Date:8/27/2008

CHAPEL-EN-LE-FRITH, England and MILPITAS, California, August 27 /PRNewswire/ -- Peakdale Molecular Ltd (CHAPEL-EN-LE-FRITH, UK) a leading provider in specialist chemistry services to the pharmaceutical and biotechnology industry, and ChemPrintCo LLC (MILPITAS, CA, USA), a unique and cost-effective provider of products and systems for the biotechnology industry, today announce the launch of AssayReady4U(TM).

AssayReady4U(TM) is an online based storefront which allows drug discovery researchers the ability to search, design and select compounds from a live physical collection of screening compounds. Then, using additional options, build their final assay by selecting the exact amount and concentration required to perform their own unique experiments.

The final customer-selected compounds are cleanly and accurately dispensed into SBS standard well plates of the customer's choosing using ChemPrintCo's sophisticated and proprietary hydro-acoustic technologies. Each AssayReady4U plate is sealed in an argon environment and then vacuum-sealed in a moisture barrier bag and placed inside a temperature-controlled pack for shipment. All orders are shipped from stock within 24 hours of completion using a commercial carrier. Upon receipt, the customer adds an appropriate amount of solvent to reach the desired test concentration.

Peakdale's collection is fundamentally rich in novel, GPCR-targeted compounds. All compounds in the collection are selected for their applicability to GPCR research. Well-recognized ligand features are combined with proprietary scaffolds and monomers to produce a set of screening compounds for GPCR hit discovery.

Glenn Killingworth, Director of Business Development at Peakdale said: "I am excited that we have built this collaboration in order to reach the smaller drug-research groups who don't want to build assets to store, handle and plate compounds, but just want to receive ready-to-screen assays from a high quality collection, in exactly the format that they need to perform their drug discovery work."

Peakdale's Director of Technology Paul Doyle said: "This represents an exciting new technology that allows a much broader base of researchers to access the world of diverse compounds in a cost effective manner."

Adding to this, ChemPrintCo's Vice President of Sales Ron Jones said: "The AssayReady4U(TM) products will be offered via an innovative web-based one-stop shopping storefront. The researchers will effortlessly select compounds, assay test concentration, plate format, plate manufacturer and controls with a few clicks of a mouse thus optimizing their valuable time for research."

About Peakdale Molecular

Peakdale Molecular was founded in 1992. Today the company's customers include the majority of the major global pharmaceutical businesses and a rapidly growing base of biotechnology companies worldwide. Peakdale's teams of chemists combine experience in pharmaceutical R&D, medicinal chemistry, parallel synthesis, process development and fine chemicals to deliver unique chemistry solutions to a range of drug discovery challenges. Peakdale has growing capabilities in computational chemistry, analytical chemistry and ADME screening.

The application of less commonly used chemistry, including high temperature/pressure reactions, proprietary heterocyclic chemistry and nucleoside synthesis, enables Peakdale's chemists to generate unique compounds for drug discovery. Peakdale operates in several distinct markets providing novel screening compounds, targeted screening libraries, catalogue intermediates, custom synthesis and contract research. Further information about the company can be obtained at http://www.peakdale.com

About ChemPrintCo LLC

ChemPrintCo is a privately held company located in the heart of Silicon Valley and the Bay Area's deep biotech and pharmaceutical community. The management team has been together for over 15 years developing unique and cost-effective products and systems for the biotech and high-technology industries. Their mission is to address the needs of the individual scientific researcher with ready-to-use assays in a single-use well plate format. We accomplish this by giving each researcher the ability to select compounds from leading suppliers in the exact amount and concentration required to perform their own unique experiments.

For more information please contact

Peakdale Molecular Ltd ChemPrintCo LLC

Glenn Killingworth Roger Williams

Director of Business Development President

Peakdale Molecular Ltd ChemPrintCo. LLC

Peakdale Science Park 1804 McCarthy Boulevard

Sheffield Road Milpitas

Chapel-en-le-Frith California

High Peak 95035

UK USA

Tel +44(0)1298-816700 Tel +1-408-273-2300

Fax +44(0)1298-816701

http://www.peakdale.com/AssayReady4U.htm

http://chemprintco.googlepages.com/home


'/>"/>
SOURCE Peakdale Molecular Ltd and ChemPrintCo LLC
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Peakdale Molecular Announces GBP 1 Million Funding to Support Expansion and Growth
2. PAREXEL Data Indicate U.S. Marketing Applications for New Molecular Entities Bounce Back
3. VisEn Announces Commercial Launch of IntegriSenseTM Fluorescence Molecular Imaging Agent
4. Molecular sleuths track evolution through the ribosome
5. Amsterdam Molecular Therapeutics Reports Half Year Results 2008
6. Molecular Biometrics Announces Results of Parkinsons Disease Research and Receipt of Grant From Michael J. Fox Foundation to Advance Diagnostic Technology
7. Dr. George Poste Named Non-Executive Vice Chairman of CDX Holdings, Parent of Caris Diagnostics and Caris Molecular Diagnostics
8. New Turbomolecular Pumping System From Varian, Inc. Delivers Portable, Dry, Ultra-high Vacuum.
9. Xceed Molecular to Launch New Inflammation Xpress Chip(TM)for the Ziplex(R) Automated Gene-Expression Analysis System at Clinical Lab Expo 2008, Booth 2155
10. Molecular hula hoop
11. Noted Molecular Epidemiologist Joins Cepheid to Head Healthcare Associated Infection Consortium Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/29/2017)... Germany , March 29, 2017 QIAGEN ... STANDARD: QIA) today announced the U.S. launch of its ipsogen ... cleared by the U.S. Food and Drug Administration as a qualitative in vitro ... extracted from EDTA whole blood.* ... ipsogen JAK2 assay is processed on QIAGEN,s Rotor-Gene ® Q MDx ...
(Date:3/29/2017)... TIKVAH, Israel , March ... (NASDAQ: BCLI), a leading developer of adult ... financial results for the year ended December ... highly successful and pivotal year for Brainstorm, with a ... made on clinical, regulatory and operational fronts," said ...
(Date:3/29/2017)... , March 29, 2017  Halozyme Therapeutics, Inc. ... and drug-delivery therapies, today announced that an Oncologic ... Drug Administration voted 11 to 0 that the ... injection was favorable for patients in the proposed ... and chronic lymphocytic leukemia. The FDA action date ...
(Date:3/29/2017)... ... March 29, 2017 , ... Bactana Animal Health, a ... the world’s food supply through enhancement of the gut microbiota, today announced the closing ... Connecticut Innovations , New York-based Sustainable Income Capital Management, LLC and a number of ...
Breaking Biology Technology:
(Date:2/14/2017)... Feb. 14, 2017  Wake Forest Baptist Medical Center ... new chief executive officer (CEO). Freischlag joins the medical ... D. McConnell , M.D., who last year announced that ... Medical Center, after leading it since 2008.   ... of Wake Forest Baptist,s academic health system, which includes ...
(Date:2/13/2017)... WASHINGTON , Feb. 13, 2017 Former ... U.S. Senate Judiciary Committee, Janice Kephart of ... regarding President Donald Trump,s "Executive Order: Protecting ... States" (Jan. 27, 2017):  "As President Trump,s ... 9th Circuit has now essentially banned the travel ban, ...
(Date:2/9/2017)... LONDON , Feb. 9, 2017 The ... in-depth analysis of the biomass boiler market globally in ... sales of biomass boilers. The market for biomass boilers ... product type, end-user, application, and country/region. The market based ... agriculture & forest residues, biogas & energy crops, urban ...
Breaking Biology News(10 mins):